{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:21:04Z","timestamp":1795022464637,"version":"4.10.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:p>Thrombotic complications, particularly stroke, are significant causes of morbidity in children with sickle cell disease (SCD). While the Factor V Leiden (FVL) G1691A mutation is a recognized genetic risk factor for thrombophilia in Caucasian and Middle Eastern populations, its role in African pediatric SCD patients remains unclear. To determine the prevalence of the FVL G1691A mutation and its association with activated protein C resistance in Sudanese pediatric SCD patients with a history of cerebrovascular accidents. This descriptive cross-sectional study was conducted from December 2015 to May 2016 at Jaafar Ibn Auf Specialized Hospital for Children in Khartoum, Sudan. One hundred Sudanese children (&lt;18 years) with homozygous SCD and documented cerebrovascular accidents were recruited. Genotyping for FVL was performed using allele-specific polymerase chain reaction (PCR), and activated protein C resistance was assessed using a clotting-based assay. Demographic, clinical, and familial data, including tribal affiliation and parental consanguinity, were collected. Data were analyzed using SPSS V29. Among the 100 participants (mean age 6.1\u2005\u00b1\u20053.3 years; 57% male), 2% were heterozygous for the FVL mutation (GA genotype), and none were homozygous mutants. Both heterozygous individuals demonstrated resistance to activated protein C. Parental consanguinity was reported in 79% of cases. No other FVL-associated thrombophilia was detected in the remaining 98 patients, all of whom had the wild-type genotype. The FVL mutation is rare among Sudanese pediatric SCD patients with stroke, suggesting it is unlikely to be a significant contributor to thrombosis risk in this population. These findings support the need for broader genetic and clinical investigations to identify more relevant risk factors and inform stroke prevention strategies in African children with SCD.<\/jats:p>","DOI":"10.1097\/md.0000000000045433","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:00Z","timestamp":1761332460000},"page":"e45433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Screening of Factor V Leiden mutation and activated protein C resistance in Sudanese children with sickle cell disease and stroke: A descriptive cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-767X","authenticated-orcid":false,"given":"Ashgan A.","family":"Ahmed","sequence":"first","affiliation":[{"name":"Faculty of Medical and Health Sciences, Liwa College, Al Ain, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-0340","authenticated-orcid":false,"given":"Reem","family":"Eltayeb","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, College of Applied Medical Science, University of Ha\u2019il, Ha\u2019il, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaida","family":"Alsaif","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, College of Applied Medical Science, University of Ha\u2019il, Ha\u2019il, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Siddeeg","sequence":"additional","affiliation":[{"name":"College of Graduate Studies, Faculty of Medical Laboratory Sciences, Sudan International University, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Nasreldeen","sequence":"additional","affiliation":[{"name":"College of Graduate Studies, Faculty of Medical Laboratory Sciences, Sudan International University, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa","family":"Elhag","sequence":"additional","affiliation":[{"name":"College of Graduate Studies, Faculty of Medical Laboratory Sciences, Sudan International University, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alimam","sequence":"additional","affiliation":[{"name":"College of Graduate Studies, Faculty of Medical Laboratory Sciences, Sudan International University, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4718-0408","authenticated-orcid":false,"given":"Eltayeb","family":"Abdalla","sequence":"additional","affiliation":[{"name":"MedStat Research Centre, Khartoum, Sudan"},{"name":"Faculty of Medicine, University of Khartoum, Khartoum, Sudan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review.","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease.","volume":"14","author":"Sundd","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2352-3026(21)00191-5","article-title":"Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care.","volume":"8","author":"Esoh","year":"2021","journal-title":"Lancet Haematol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"2333794X18774970","DOI":"10.1177\/2333794X18774970","article-title":"Stroke prevalence in children with sickle cell disease in Sub-Saharan Africa: a systematic review and meta-analysis.","volume":"5","author":"Marks","year":"2018","journal-title":"Glob Pediatr Health"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","article-title":"Central nervous system complications and management in sickle cell disease.","volume":"127","author":"Debaun","year":"2016","journal-title":"Blood"},{"key":"R6-20261118","first-page":"103815","article-title":"Moyamoya syndrome and stroke among pediatric sickle cell disease patients in Sudan: a cross-sectional study.","volume":"78","author":"Elmahdi","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem.","volume":"2007","author":"Ataga","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia.","volume":"13","author":"Kujovich","year":"2010","journal-title":"Genet Med"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C.","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"R10-20261118","first-page":"33","article-title":"Association of FV leiden G 1690 A and prothrombin G 20210 in coagulation activation of sudanese sickle cell anemia patients.","volume":"5","author":"Hussein","year":"2020","journal-title":"Int J Mol Biol"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/JBM.S308997","article-title":"Prevalence of Factor V Leiden G1691A and prothrombin G20210A gene mutation among pregnant women: experience from a multi-center study in Nigeria.","volume":"12","author":"John-Olabode","year":"2021","journal-title":"J Blood Med"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1096-8652(199809)59:1<46::AID-AJH9>3.0.CO;2-#","article-title":"Prothrombin Mutant, Factor V Leiden, and thermolabile variant of methylenetetrahidrofolate reductase among patients with sickle cell disease in Brazil.","volume":"59","author":"Andrade","year":"1998","journal-title":"Am J Hematol"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1076029611425830","article-title":"Prevalence of Factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.","volume":"18","author":"Pandey","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<12::AID-AJH2>3.0.CO;2-7","article-title":"Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease.","volume":"54","author":"Kahn","year":"1997","journal-title":"Am J Hematol"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12878-018-0097-0","article-title":"Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease.","volume":"18","author":"Samarah","year":"2018","journal-title":"BMC Hematol"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajh.20087","article-title":"Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.","volume":"76","author":"Fawaz","year":"2004","journal-title":"Am J Hematol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11239-007-0069-x","article-title":"Thrombophilic mutations among Southern Iranian patients with sickle cell disease: High prevalence of factor V Leiden.","volume":"25","author":"Rahimi","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/03630269.2018.1451340","article-title":"Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T and A1298C mutations in patients with sickle cell disease in Tunisia.","volume":"42","author":"Belhaj Nefissi","year":"2018","journal-title":"Hemoglobin"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"101595","DOI":"10.1016\/j.genrep.2022.101595","article-title":"Thrombophilic mutations and risk of vascular complications in sickle cell disease.","volume":"27","author":"Sokkar","year":"2022","journal-title":"Gene Rep"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"e2011037","DOI":"10.4084\/mjhid.2011.037","article-title":"Epidemiology of activated protein c resistance and Factor V Leiden mutation in the Mediterranean region.","volume":"3","author":"Jadaon","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"100101","DOI":"10.1016\/j.tru.2022.100101","article-title":"Risk factors for venous thromboembolism and clinical outcomes in adults with sickle cell disease.","volume":"6","author":"Scarpato","year":"2022","journal-title":"Thromb Update"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/bloodadvances.2019001384","article-title":"Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease.","volume":"4","author":"Srisuwananukorn","year":"2020","journal-title":"Blood Adv"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.15171\/npj.2019.16","article-title":"Factor V Leiden and prothrombin G20210A mutations and risk of vaso-occlusive complications in sickle cell disease: a meta-analysis through the lens of nephrology.","volume":"8","author":"Bhaskar","year":"2019","journal-title":"J Nephropharmacol"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.3390\/jcm12206498","article-title":"Predisposing factors and incidence of venous thromboembolism among hospitalized patients with sickle cell disease.","volume":"12","author":"Ziyadah","year":"2023","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:00:51Z","timestamp":1795021251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":24,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045433","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-07-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}